Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion type Assertion NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_head.
- NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion description "[This is the first report implicating BRAF mutation in OSCC. Our study supports that mutations in the BRAF, KRAS, and PIK3CA genes make at least a minor contribution to OSCC tumorigenesis, and pathway-specific therapies targeting these 2 pathways should be]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_provenance.
- NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion evidence source_evidence_literature NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_provenance.
- NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion SIO_000772 20813562 NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_provenance.
- NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion wasDerivedFrom gad-20150221 NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_provenance.
- NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_assertion wasGeneratedBy ECO_0000203 NP185037.RAfkxmZ35ELSMggJszEJZZt4gWU0zOcIoUp2CCYXMo_Jg130_provenance.